Government’s budget allocation for Department of Biotechnology boosted by 65% during the last four years

2018-06-08 09:07:44

The investment in Science, Technology and related areas has gone up during the last four years starting 2014-15 to 2018-19, as against five years earlier, i.e., 2009-10 to 2013-14. The budget allocation to Department of Science & Technology was Rs. 19,764 crores, which is a 90% increase. Similarly, there was an increase of 65% for the Department of Biotechnology. By Team ABLEThe Union Minister

Read more

Contract research company AMRI bags seven-year NIH contract

2018-06-08 09:04:24

AMRI\'s activities under the contract will focus on the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies.By Team ABLEAMRI, a global contract research, development and manufacturing organization, has secured a seven-year contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes

Read more

Pfizer makes $600 million commitment to Pfizer Ventures; 25% of funding dedicated to Neuroscience study

2018-06-08 09:03:26

Pfizer Inc. has announced its plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures. By Team ABLEPfizer Inc. has announced its plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company’s venture investment vehicle.  In addition to increased funding, Pfizer will extend its leaders

Read more

Global Virus Network’s Centers of Excellence to contribute expertise to Nipah Virus Outbreak in Kerala

2018-06-08 09:02:01

In the wake of the outbreak, the Government of Kerala is fast-tracking the launch of the Institute of Advanced Virology, which will house a unit of the GVNBy Team ABLESeveral of the Global Virus Network’s (GVN) Centers of Excellence have been researching Nipah virus (NiV) and are currently contributing expertise to the outbreak in the Indian state of Kerala. India’s latest deadly NiV outbreak

Read more

Vasudev Tribhuvan joins Wellthy Therapeutics from Biocon

2018-06-08 08:59:26

Vasudev, previously employed with Biocon, joins Wellthy Therapeutics as Vice President, Partnerships & AlliancesBy Team ABLEWellthy Therapeutics has appointed Vasudev V. Tribhuvan as Vice President, Partnerships & Alliances with effect from May 2018. Vasudev’s previous role was at Biocon, where he was the Senior Director, Marketing and led strategic initiatives for the metabolic unit whi

Read more

Bangalore’s Kemwell Biopharma to manufacture Monoclonal Antibody Drug Substance for a US phase 3 clinical trial

2018-06-08 08:58:39

Kemwell will manufacture and supply drug substance using its mammalian cell culture plant in India for Phase 3 clinical trials that will be conducted in the US. By Team ABLEKemwell Biopharma, a Bangalore-based biologics contract development and manufacturing service provider, has signed a contract to manufacture and supply drug substance using its state-of-the-art mammalian cell culture plant in I

Read more

BCIL licenses technologies to Rcupe Lifesciences and UNINO Healthcare

2018-06-08 08:57:41

Biotech Consortium India Limited has licensed Intraosseous Device technology to Rcupe Lifesciences and pleuraGoh technology to UNINO HealthcareBy Team ABLEBCIL-RcupeLifesciences technology transferThe Biotech Consortium India Limited (BCIL) has licensed Intraosseous Device technology to Rcupe Lifesciences Pvt Ltd., Bangalore, a start-up company in the presence of Dr. Renu Swarup, Secretary, DBT an

Read more

UK’s Premaitha collaborates with Indian diagnostic firm for non-invasive prenatal testing products launch

2018-06-08 08:56:10

Premaitha, through its Yourgene subsidiary, has entered into a partnership with one of India\'s leading diagnostic groups, to offer mass-population NIPT screeningBy Team ABLEManchester-located, Premaitha Health plc, an international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), has announced a three-year agreement with an undisclosed advanced clinical laboratory grou

Read more

US FDA approves Mylan-Biocon’s Neulasta biosimilar Fulphila

2018-06-08 08:55:17

Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce the risk of infection following myelosuppressive chemotherapy. By Team ABLEMylan N.V. and Biocon Ltd have announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim), co-deve

Read more

AP Med Tech Park bags International Clinical Engineering Award

2018-06-08 08:51:13

AP Med Tech Park has announced that the park has bagged the 2018 American College of Clinical Engineering (ACCE) International Award. By Team ABLEThe American College of Clinical Engineering in collaboration with the Healthcare Technology Foundation (ACCE/HTF) has conferred the “International Organization Award” to Andhra Pradesh MedTech Zone (AMTZ) during the 28th ACCE annual meeting held on

Read more